2-(((tert-Butoxycarbonyl)amino)methyl)-2,4-dimethylpentanoic acid

Catalog No.: 
ACZIRV845
CAS No.: 
1694122-93-4
Molecular Formula: 
C13H25NO4
Molecular Weight: 
259.35
2-(((tert-Butoxycarbonyl)amino)methyl)-2,4-dimethylpentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$143.00InquiryInquiry
100mg98%$208.00InquiryInquiry
250mg98%$287.00InquiryInquiry
1g98%$678.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(((tert-Butoxycarbonyl)amino)methyl)-2,4-dimethylpentanoic acid
IUPAC Name2-(((tert-butoxycarbonyl)amino)methyl)-2,4-dimethylpentanoic acid
Molecular FormulaC13H25NO4
Molecular Weight259.35
SMILESCC(C)CC(C)(CNC(OC(C)(C)C)=O)C(O)=O
InChI KeyLUATXGHBESHQBK-UHFFFAOYSA-N
Synonym2-({[(tert-butoxy)carbonyl]amino}methyl)-2,4-dimethylpentanoic acid;Pentanoic acid, 2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-2,4-dimethyl-
CAS No.1694122-93-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZIRV845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZIRV845 route product structure diagram
    ACZIRV8451694122-93-4
Inquiry

2. ACZIRV845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZIRV845 route product structure diagram
    ACZIRV8451694122-93-4
Inquiry

3. ACZIRV845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZIRV845 route product structure diagram
    ACZIRV8451694122-93-4
Inquiry

Comments (0)